Position in NTRA
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$46,963,835
+$21,065,130 QoQ
Shares Held
173,011
+33.6% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#97
of 846 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Erste Asset Management GmbH holds $200,838,814 across 14 Diagnostics & Research names. NTRA ranks #2 (23.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
577,313 | $86,614,269 | |
| 2 | NTRA |
Natera, Inc.
This page
|
173,011 | $46,963,835 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
52,090 | $26,115,842 | |
| 4 | A |
Agilent Technologies, Inc.
|
119,272 | $15,842,899 | |
| 5 | ILMN |
Illumina, Inc.
|
72,650 | $12,774,049 | |
| 6 | DHR |
Danaher Corp /De/
|
38,695 | $7,370,623 | |
| 7 | WAT |
Waters Corp /De/
|
8,268 | $3,100,830 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
3,092 | $1,627,752 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,963,835 | 173,011 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $25,898,705 | 129,500 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $28,979,885 | 126,500 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $18,753,005 | 116,500 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $16,302,710 | 96,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,343,395 | 9,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,216,200 | 14,000 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||